Parvez Mantry, MD, shares real-world resmetirom data from AASLD 2026, including GLP-1 combination use and biopsy-sparing monitoring.
|Articles|January 2, 2009
The Co-Pay Connection - Dr. A. Mark Fendrick of the University of Michigan
Author(s)A. Mark Fendrick, MD
Dr. A. Mark Fendrick explains the concept of Value-Based Insurance Design (VBID) and how it works.
Advertisement
Our Co-Editor-in-Chief, Dr. A. Mark Fendrick, explains the concept of Value-Based Insurance Design (VBID) and discusses the implications of reducing co-pays for employers and insurers.
Advertisement
Related to this article
Michael Mina, MD, PhD, of Invivyd, on measles antibody VMS063, immune amnesia, and what RSV antibody uptake signals for payers.
Advertisement
Advertisement
Trending on AJMC
1
Survodutide Meets CV Safety End Point in SYNCHRONIZE-CVOT
2
FDA Approves First Dual-Targeted Therapy for Advanced HNSCC
3
Data Show Upadacitinib Repigments Skin in Nonsegmental Vitiligo
4
Oral Iberdomide May Widen Myeloma Access: Mateo Mejia Saldarriaga, MD
5